Othman Al-Sawaf, MD

Articles by Othman Al-Sawaf, MD

What Is the Best Strategy for Frontline Venetoclax Plus Obinutuzumab in CLL?

Othman Al-Sawaf, MDChronic Lymphocytic Leukemia | September 24, 2023

Othman Al-Sawaf, MD, and Nicole Lamanna, MD, debate approaches in this Point | Counterpoint.